COVID-19–associated multisystem inflammatory syndrome in children
MONDO:0100163A inflammatory syndrome in children infected by the SARS-CoV-2 with similarities to Kawasaki disease. Clinical manifestations range from fever and inflammation to myocardial injury, shock, and development of coronary artery aneurysms.
Also known as: COVID-19 -related paediatric inflammatory multisystem syndrome, COVID-19 -related pediatric inflammatory multisystem syndrome, COVID-19 Kawasaki-like syndrome, COVID-19 associated multisystem inflammatory syndrome in children, MIS-C, PIMS, PIMS-TS, PMIS
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Experimental stem cells offered to kids with rare COVID complication
Disease control NO_LONGER_AVAILABLEThis study provides early access to an experimental stem cell treatment called remestemcel-L for children aged 2 months to 17 years with MIS-C, a severe inflammatory condition linked to COVID-19. The treatment aims to calm the immune system and reduce inflammation. Participants r…
Sponsor: Mesoblast International Sàrl • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Scientists compare immune responses to viral and bacterial infections in ICU patients
Knowledge-focused OngoingThis study looks at how the immune system of patients in the intensive care unit (ICU) responds to severe infections caused by viruses or bacteria. Researchers will take extra blood samples from 38 adults to analyze immature granulocytes, a type of immune cell. The goal is to see…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Tracking Kids' hearts years after rare COVID-19 complication
Knowledge-focused OngoingThis study follows 1,200 children and young adults who had MIS-C, a rare inflammatory condition linked to COVID-19. Researchers will track heart function and other health outcomes over time using echocardiograms and medical records. The goal is to understand the long-term effects…
Sponsor: Carelon Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can we cut back on bladder drugs for seniors? new study aims to find out
Knowledge-focused OngoingThis study tests a guideline designed to help doctors safely reduce or stop overactive bladder medications in people aged 65 and older. Researchers will compare how many patients continue these drugs after six months between those whose doctors follow the guideline and those who …
Phase: NA • Sponsor: Anne Estrup Olesen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC